Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul Alpern sold 2,278 shares of the company's stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $8.69, for a total value of $19,795.82. Following the sale, the vice president owned 73,587 shares in the company, valued at approximately $639,471.03. This trade represents a 3.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Arteris Stock Performance
AIP stock traded down $0.06 during midday trading on Wednesday, reaching $8.66. 663,098 shares of the company traded hands, compared to its average volume of 550,932. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.29. The business has a 50 day moving average of $9.50 and a 200-day moving average of $8.22. The firm has a market capitalization of $369.35 million, a price-to-earnings ratio of -10.56 and a beta of 1.44.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The business had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current year.
Wall Street Analyst Weigh In
AIP has been the topic of several recent analyst reports. TD Cowen increased their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Wall Street Zen downgraded Arteris from a "hold" rating to a "sell" rating in a report on Sunday. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $15.00.
Read Our Latest Research Report on Arteris
Institutional Trading of Arteris
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Arteris in the 1st quarter worth $95,000. Two Sigma Advisers LP boosted its position in shares of Arteris by 82.9% in the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company's stock worth $240,000 after purchasing an additional 10,700 shares in the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Arteris in the 4th quarter worth $214,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Arteris in the 4th quarter worth $117,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Arteris in the 4th quarter worth $160,000. Institutional investors own 64.36% of the company's stock.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.